This final part of the three-part video series highlights Sharon Faust of Navitus reflecting on how personal challenges, including her husband’s accident, reshaped her perspective and empowered her to ...

Papzimeos is the first and only FDA-approved treatment for adults with recurrent respiratory papillomatosis (RRP), with ongoing clinical studies showing symptom relief for up to two years.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive (MHE) editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen ...

HHS reinstates the Task Force on Safer Childhood Vaccines to enhance vaccine safety and oversight amid concerns over recent ACIP changes.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

The Inflation Reduction Act’s $2,000 cap on out-of-pocket costs for prescription drugs is expected to change Medicare beneficiaries’ use of medications, potentially leading to different utilization ...

The FDA has granted accelerated approval to Hernexeos (zongertinib), making it the first oral targeted therapy for previously treated adults with advanced lung cancer driven by HER2 mutations. HER2 ...

An expert discusses the approval of a third bispecific antibody for relapsed/refractory multiple myeloma (R/R MM), highlighting its potential to reshape treatment pathways, intensify payer scrutiny ...

U.S. employers project a median healthcare cost increase of 10% for 2026, according to new survey results from the International Foundation of Employee Benefit Plans. The survey was done from July 30, ...

In this video interview, Amanda Bogle, a healthcare attorney at Sheppard Mullin, explains the importance of compliance officers, documentation systems and leadership for pharmacists looking to adhere ...

An expert discusses the evolving role of bispecific antibodies in multiple myeloma, highlighting their off-the-shelf availability, immune-targeting mechanism, and growing potential in relapsed and ...

An expert discusses the operational and financial complexities of integrating bispecific antibodies into multiple myeloma treatment pathways, emphasizing the need for standardized protocols, ...